USP32 and breast cancer: Through a series of preliminary pan-cancer analyses, we discovered that USP32 is significantly overexpressed in several cancer types such as BC, cholangiocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, HCC and GC (Fig. 1A).